Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004027117 | SCV003539312 | uncertain significance | not specified | 2022-08-08 | criteria provided, single submitter | clinical testing | The c.1623G>C (p.Q541H) alteration is located in exon 7 (coding exon 6) of the PLXNA3 gene. This alteration results from a G to C substitution at nucleotide position 1623, causing the glutamine (Q) at amino acid position 541 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Institute of Human Genetics, |
RCV000736200 | SCV000864497 | likely pathogenic | Short stature | 2001-11-18 | no assertion criteria provided | case-control |